120 related articles for article (PubMed ID: 1464470)
1. Effect of Ebselen on polymorphonuclear leukocyte adhesion to and migration through cytokine-activated vascular endothelium.
Issekutz AC; Lopes N
Int J Immunopharmacol; 1992 Nov; 14(8):1383-90. PubMed ID: 1464470
[TBL] [Abstract][Full Text] [Related]
2. The effect of ebselen on polymorphonuclear leukocyte migration to joints in rats with adjuvant arthritis.
Gao JX; Issekutz AC
Int J Immunopharmacol; 1993 Oct; 15(7):793-802. PubMed ID: 8262693
[TBL] [Abstract][Full Text] [Related]
3. The effect of ebselen on polymorphonuclear leukocyte and lymphocyte migration to inflammatory reactions in rats.
Gao JX; Issekutz AC
Immunopharmacology; 1993; 25(3):239-51. PubMed ID: 8354640
[TBL] [Abstract][Full Text] [Related]
4. Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration.
Drake WT; Lopes NN; Fenton JW; Issekutz AC
Lab Invest; 1992 Nov; 67(5):617-27. PubMed ID: 1434539
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 and tumour necrosis factor alpha induced polymorphonuclear leukocyte-endothelial cell adhesion and transendothelial migration in vitro: the effect of apical versus basal monolayer stimulation.
Morzycki W; Sadowska J; Issekutz AC
Immunol Lett; 1990 Sep; 25(4):331-40. PubMed ID: 2249877
[TBL] [Abstract][Full Text] [Related]
6. The effect of ebselen on T-lymphocyte migration to arthritic joints and dermal inflammatory reactions in the rat.
Gao JX; Issekutz AC
Int J Immunopharmacol; 1994 Apr; 16(4):279-87. PubMed ID: 8045667
[TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor-alpha but not interleukin-1 induces polymorphonuclear leucocyte migration through fibroblast layers by a fibroblast-dependent mechanism.
Morzycki W; Issekutz AC
Immunology; 1991 Sep; 74(1):107-13. PubMed ID: 1937564
[TBL] [Abstract][Full Text] [Related]
8. Synergy between tumour necrosis factor alpha and interleukin-1 in the induction of polymorphonuclear leukocyte migration during inflammation.
Wankowicz Z; Megyeri P; Issekutz A
J Leukoc Biol; 1988 Apr; 43(4):349-56. PubMed ID: 3258346
[TBL] [Abstract][Full Text] [Related]
9. Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils.
Patrick RA; Peters PA; Issekutz AC
Agents Actions; 1993 Nov; 40(3-4):186-90. PubMed ID: 8023742
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin activation of endothelium for polymorphonuclear leucocyte transendothelial migration and modulation by interferon-gamma.
Issekutz AC; Lopes N
Immunology; 1993 Aug; 79(4):600-7. PubMed ID: 8104889
[TBL] [Abstract][Full Text] [Related]
11. Ebselen inhibits tumor necrosis factor-alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells.
Yoshizumi M; Fujita Y; Izawa Y; Suzaki Y; Kyaw M; Ali N; Tsuchiya K; Kagami S; Yano S; Sone S; Tamaki T
Exp Cell Res; 2004 Jan; 292(1):1-10. PubMed ID: 14720501
[TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory drug nimesulide inhibits neutrophil adherence to and migration across monolayers of cytokine-activated endothelial cells.
Dapino P; Ottonello L; Dallegri F
Respiration; 1994; 61(6):336-41. PubMed ID: 7824814
[TBL] [Abstract][Full Text] [Related]
13. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms.
Issekutz AC; Chuluyan HE; Lopes N
J Leukoc Biol; 1995 Apr; 57(4):553-61. PubMed ID: 7722414
[TBL] [Abstract][Full Text] [Related]
14. Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury.
Tiegs G; Küsters S; Künstle G; Hentze H; Kiemer AK; Wendel A
J Pharmacol Exp Ther; 1998 Dec; 287(3):1098-104. PubMed ID: 9864298
[TBL] [Abstract][Full Text] [Related]
15. Mechanism for the inhibitory effect of a seleno-organic compound, Ebselen, and its analogues on superoxide anion production in guinea pig polymorphonuclear leukocytes.
Wakamura K; Ohtsuka T; Okamura N; Ishibashi S; Masayasu H
J Pharmacobiodyn; 1990 Jul; 13(7):421-5. PubMed ID: 1963195
[TBL] [Abstract][Full Text] [Related]
16. Ebselen--an in vivo immune response modifier.
Wendel A; Kuesters S; Tiegs G
Biomed Environ Sci; 1997 Sep; 10(2-3):253-9. PubMed ID: 9315318
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1 enhances polymorphonuclear leucocyte accumulation in dermal inflammation and transendothelial migration by a priming action.
Drake WT; Issekutz AC
Immunology; 1993 Feb; 78(2):197-204. PubMed ID: 8473013
[TBL] [Abstract][Full Text] [Related]
18. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
Pratta MA; Ackerman NR; Arner EC
Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
[TBL] [Abstract][Full Text] [Related]
19. Polymorphonuclear leucocyte migration through human dermal fibroblast monolayers is dependent on both beta 2-integrin (CD11/CD18) and beta 1-integrin (CD29) mechanisms.
Gao JX; Issekutz AC
Immunology; 1995 Jul; 85(3):485-94. PubMed ID: 7558139
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha is necessary for granulocyte-macrophage-colony-stimulating-factor-induced eosinophil transendothelial migration.
Erger RA; Casale TB
Int Arch Allergy Immunol; 1998 Jan; 115(1):24-32. PubMed ID: 9430492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
